增长差异化因素11:心血管疾病治疗的新希望
Yingchun Shao1, Yanhong Wang1, Jiazhen Xu1
1The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao 266071, China.
Cytokine & growth factor reviews
|July 6, 2023
概括
增长差异化因子11 (GDF11) 显示出治疗心脏衰老和心血管疾病 (CVD) 的前景. 这一评论详细介绍了GDF11的细节.
科学领域:
- 心血管生物学 心血管生物学
- 再生医学是一种再生医学.
- 分子信号传输的方法
背景情况:
- 增长差异化因子11 (GDF11) 是转变生长因子β超级家族中的一个关键蛋白质.
- GDF11表现出抗心脏衰老的特性,并与心血管疾病 (CVD) 的发展有关.
研究的目的:
- 综合审查GDF11的结构,功能和信号通路.
- 总结目前关于GDF11在心血管疾病发病过程中的作用的研究.
- 探索GDF11作为心血管疾病治疗点的潜力.
主要方法:
- 关于GDF11和心血管健康的研究文献综述.
- 分析GDF11的分子机制和组织特异性功能.
- 对GDF11用于心血管疾病治疗的临床前和临床研究的评估.
主要成果:
- GDF11在维持心脏功能和减轻衰老影响方面发挥着至关重要的作用.
- GDF11的失调与各种心血管疾病的进展有关.
- 新出现的证据支持GDF11在临床前心血管疾病模型中的治疗潜力.
结论:
- GDF11是心脏衰老和心血管疾病发展的重要因素.
- 对GDF11信号通路的进一步研究是治疗开发的必要条件.
- GDF11作为治疗心血管疾病的新型治疗剂具有前景.
相关概念视频
Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
TGF - β Signaling Pathway
7.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.5K
Forced Transdifferentiation
1.9K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
Artificial...
1.9K


